Related Experiment Video
Updated: Jul 16, 2026
Isokinetic Robotic Device to Improve Test-Retest and Inter-Rater Reliability for Stretch Reflex Measurements in Stroke Patients with Spasticity
Published on: June 12, 2019
Spasticity management in the child with spastic quadriplegia
M E Gormley1, L E Krach, L Piccini
1Department of Physical Medicine and Rehabilitation, Gillette Children's Specialty Healthcare, St. Paul, Minnesota 55101, USA. mgormley@gillettechildrens.com
Insights
Spasticity in children with quadriplegia or severe diplegia impacts motor function and comfort. A multidisciplinary approach integrating various treatments is crucial for optimizing care and function.
Area of Science:
- Pediatric Neurology
- Rehabilitation Medicine
- Developmental Pediatrics
Background:
- Spastic quadriplegia and severe diplegia in children significantly impair motor function, comfort, and daily care.
- Spasticity management aims to improve comfort, reduce pain, ease caregiver burden, slow deformities, and potentially enhance function.
- While treatment modalities overlap, children with severe diplegia often have a greater focus on functional ambulation goals.
Purpose of the Study:
- To outline the complexities and considerations in managing spasticity in children with spastic quadriplegia and severe diplegia.
- To highlight the range of available treatment options and the importance of integrated care.
- To emphasize the need for individualized, multidisciplinary management plans tailored to each child's unique needs and goals.
Main Methods:
- Review of current spasticity interventions for pediatric cerebral palsy, including botulinum toxin type A, phenol neurolysis, oral medications, intrathecal baclofen, selective dorsal rhizotomy, and orthopedic surgery.
- Discussion of factors influencing management decisions, such as age, nutritional status, deformity progression, developmental potential, comorbidities, functional status, prognosis, and patient/family goals.
- Emphasis on the necessity of a coordinated, multidisciplinary team approach involving medical and allied health professionals, with active family participation.
Main Results:
- Children with significant spasticity often require a combination of interventions for optimal outcomes.
- Effective management necessitates a comprehensive assessment of individual patient characteristics and treatment goals.
- Integration of various treatment modalities can optimize overall care and functional potential.
Conclusions:
- Optimizing outcomes for children with spastic quadriplegia or severe diplegia requires understanding their specific needs and the diverse treatment landscape.
- A personalized, multidisciplinary strategy, acknowledging the central role of the family, is paramount for successful spasticity management.
- Coordinated care planning by a specialized team can maximize functional potential and improve quality of life for affected children.
Abstract:
In children with spastic quadriplegia, also described as 'whole body involvement', spasticity can interfere with motor function, contributes to the development of deformities and adversely impacts on care, positioning, and comfort. In this population, spasticity interventions address goals such as improving comfort, reducing pain, easing the burden of carers, slowing the progression of musculoskeletal deformities and perhaps improving function. Children with severe diplegia are distinguished from those with quadriplegia by their ability to ambulate, as well as by a greater emphasis being placed on functional motor goals even though similar treatment modalities are often employed to manage spasticity. The many treatment options currently available include, but are not limited to, botulinum toxin type A, phenol neurolysis, oral medications, intrathecal baclofen, selective dorsal rhizotomy, and orthopaedic surgery. The integration of these treatment modalities can help to optimize the overall care and function for a child with spastic quadriplegia or severe diplegia. However, the development of a management programme is complex and needs to take into account many factors, including age, weight and nutritional status, rate of progression of musculoskeletal deformities, developmental potential, comorbid conditions, current functional status and prognosis, and family and patient treatment goals. Children with marked spasticity are likely to benefit from a combination of interventions, rather than a single treatment modality. Because of these complexities, management should be planned and coordinated by a multidisciplinary team of medical and allied health professionals which recognizes the central role of the family in all decisions. Once the special characteristics of the child with spastic quadriplegia and the various treatment options are understood, outcomes can be maximized.
More Related Videos
Related Concept Videos
01:28Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
01:29Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
01:12Alterations in Muscle Tone ll